Terms: = Skin cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Treatment
142 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. Epidermal growth factor receptor inhibitors in advanced cutaneous squamous cell carcinoma: A systematic review and meta-analysis.
Pham JP; Rodrigues A; Goldinger SM; Sim HW; Liu J
Exp Dermatol; 2024 Jan; 33(1):e14978. PubMed ID: 37971204
[TBL] [Abstract] [Full Text] [Related]
3. Cost-utility analysis of Pembrolizumab compared to other alternative immunotherapy and chemotherapy treatments for patients with advanced melanoma in Iran.
Bashari N; Safaei Lari M; Darvishi A; Daroudi R
Expert Rev Pharmacoecon Outcomes Res; 2024 Feb; 24(2):273-284. PubMed ID: 37750606
[TBL] [Abstract] [Full Text] [Related]
4. Current Patterns of treatment and Outcomes in Advanced Melanoma at a Single Institution.
Rose MA; Miura J; Sharon C; Ermer JP; Karakousis G; Wachtel H
J Surg Res; 2023 Nov; 291():25-33. PubMed ID: 37331189
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma.
Huang R; Shen G; Ren Y; Zheng K; Wang J; Shi Y; Yin JC; Qin L; Zhang G; Zhao M; Su X; Li L; Wang F; Shao Y; Liu B; Zou Z
J Transl Med; 2023 Feb; 21(1):78. PubMed ID: 36739402
[TBL] [Abstract] [Full Text] [Related]
6. Genomic Alterations and Tumor Mutation Burden in Merkel Cell Carcinoma.
Brazel D; Kumar P; Doan H; Pan T; Shen W; Gao L; Moyers JT
JAMA Netw Open; 2023 Jan; 6(1):e2249674. PubMed ID: 36602798
[TBL] [Abstract] [Full Text] [Related]
7. Melanoma treatments and Mortality Rate Trends in the US, 1975 to 2019.
Kahlon N; Doddi S; Yousif R; Najib S; Sheikh T; Abuhelwa Z; Burmeister C; Hamouda DM
JAMA Netw Open; 2022 Dec; 5(12):e2245269. PubMed ID: 36472871
[TBL] [Abstract] [Full Text] [Related]
8. LINC01296 promotes proliferation of cutaneous malignant melanoma by regulating miR-324-3p/MAPK1 axis.
Wang K; Luo Q; Zhang Y; Xie X; Cheng W; Yao Q; Chen Y; Ren H; Li J; Pan Z
Aging (Albany NY); 2022 Dec; 15(8):2877-2890. PubMed ID: 36462499
[TBL] [Abstract] [Full Text] [Related]
9. PD-1 and CTLA-4 inhibitors in combination vs. alone for the treatment of advanced melanoma: A systematic review and meta-analysis.
He R; Zhao X; Liu J; Zhou Y; Zhang X; Cheng F
Medicine (Baltimore); 2022 Oct; 101(41):e30561. PubMed ID: 36254050
[TBL] [Abstract] [Full Text] [Related]
10. Association of electrochemical skin conductance with neuropathy in chemotherapy-treated patients.
Mahfouz FM; Park SB; Li T; Timmins HC; Horvath LG; Harrison M; Grimison P; King T; Goldstein D; Mizrahi D
Clin Auton Res; 2022 Dec; 32(6):497-506. PubMed ID: 36129622
[TBL] [Abstract] [Full Text] [Related]
11. Effects of the COVID-19 pandemic on care of melanoma patients in Berlin, Germany: the Mela-COVID survey.
Teuscher M; Diehl K; Schaarschmidt ML; Weilandt J; Sasama B; Ohletz J; Könnecke A; Harth W; Hillen U; Peitsch WK
Eur J Dermatol; 2022 Jul; 31(4):521-529. PubMed ID: 36094385
[TBL] [Abstract] [Full Text] [Related]
12. Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract cancer: A Phase II T1219 Study.
Chiang NJ; Tan KT; Bai LY; Hsiao CF; Huang CY; Hung YP; Huang CJ; Chen SC; Shan YS; Chao Y; Huang YH; Lee IC; Lee PC; Su YY; Chen SJ; Yeh CN; Chen LT; Chen MH
Clin Cancer Res; 2022 Oct; 28(19):4248-4257. PubMed ID: 35849151
[TBL] [Abstract] [Full Text] [Related]
13. In silico-prediction of chloroquine as a multi-targeted drug against CDKN2A signaling network associated with cutaneous malignant melanoma.
Jan Z; Aqeel M; Munir A; Saeed A; Sadia H; Kalsoom S; Nadeem T; Bashir Z; Awan L; Ud Din S; Muhammad Ali G
Pak J Pharm Sci; 2022 May; 35(3):731-739. PubMed ID: 35791470
[TBL] [Abstract] [Full Text] [Related]
14. Variable Genomic Landscapes of Advanced Melanomas with Heavy Pigmentation.
Huang RSP; Tse JY; Harries L; Graf RP; Lin DI; Murugesan K; Hiemenz MC; Parimi V; Janovitz T; Decker B; Severson E; Levy MA; Ramkissoon SH; Elvin JA; Ross JS; Williams EA
Oncologist; 2022 Aug; 27(8):655-662. PubMed ID: 35552752
[TBL] [Abstract] [Full Text] [Related]
15. [Pretreatment evaluation of
Peng P; Wu N; Tao XL; Liu Y; Lyu L; Cheng X
Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):370-376. PubMed ID: 35448927
[No Abstract] [Full Text] [Related]
16. Topical gel of mesenchymal stem cells-conditioned medium under TNF-α precondition accelerates wound closure healing in full-thickness skin defect animal model.
Putra A; Ibrahim S; Muhar AM; Kuntardjo N; Dirja BT; Pasongka Z; Tunru IS
J Med Life; 2022 Feb; 15(2):214-221. PubMed ID: 35419097
[TBL] [Abstract] [Full Text] [Related]
17. Safety and Efficacy of Bis-Glyceryl Ascorbate as Prophylaxis for Hand-Foot skin Reaction: A Single-Arm, Open-Label Phase I/II Study (DGA Study).
Yamamoto K; Nishiyama S; Kunisada M; Iida M; Ito T; Ioroi T; Makimoto H; Omura T; Harada K; Fujisawa M; Nishigori C; Yano I
Oncologist; 2022 May; 27(5):e384-e392. PubMed ID: 35285503
[TBL] [Abstract] [Full Text] [Related]
18. Outcomes After Curative Metastasectomy for Patients with Malignant Melanoma: A Systematic Review and Meta-analysis.
Wankhede D; Grover S
Ann Surg Oncol; 2022 Jun; 29(6):3709-3723. PubMed ID: 35128602
[TBL] [Abstract] [Full Text] [Related]
19. Incidence and mortality of uveal melanoma in Australia (1982-2014).
Beasley AB; Preen DB; McLenachan S; Gray ES; Chen FK
Br J Ophthalmol; 2023 Mar; 107(3):406-411. PubMed ID: 34880052
[TBL] [Abstract] [Full Text] [Related]
20. Near-infrared photoimmunotherapy for the treatment of skin disorders.
Russo I; Fagotto L; Colombo A; Sartor E; Luisetto R; Alaibac M
Expert Opin Biol Ther; 2022 Apr; 22(4):509-517. PubMed ID: 34860146
[TBL] [Abstract] [Full Text] [Related]
[Next]
